Paxil class action
Executive Summary
Plaintiffs claiming Paxil is habit-forming will resubmit motion for class action certification after Los Angeles district court denied certification request Jan. 10, citing viability concerns for multi-state action. The court earlier denied the plaintiff's request to enjoin GSK from airing ads with "Paxil is non-habit forming" claim (1"The Pink Sheet" Aug. 26, 2002, p. 21)...
You may also be interested in...
Paxil TV Ad Case Could Produce Ruling On FDA’s Authority To Regulate Ads
A suit regarding claims in Paxil TV ads could produce a court ruling regarding FDA's authority to regulate advertising
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.